Obesity in Children
5
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Glp1 Receptor Agonist
Research Leaders
13 sponsors active, led by Danish Research Centre for Migration, Ethnicity and Health, University of Copenhagen
Related Conditions
Often studied with 12 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
The Bloom Study - a Safe and Healthy Start in Life
Overview: Use of Respiratory Support At Home in Children
Habituation to Food as a Risk Factor for Pediatric Obesity
Technology Based Obesity Prevention Project (TeBOPP)
Research Network
Common Treatments
- Glp1 Receptor Agonist1
- Multibehavioural1
- Video Game Based Obesity Education1
- Standardized Assessments1
- Lifestyle Intervention1
Active Sponsors
- Danish Research Centre for Migration, Ethnicity and Health, University of Copenhagen1
- University Hospital, Grenoble1
- University of Southern Denmark1
- University of Copenhagen1
- Valleywise Health1
Top Investigators
University of Virginia
University of Southern Denmark
University at Buffalo
District Medical Group
Related Conditions
- Storage Disease1
- Overweight Childhood1
- Bone Strength1
- Bronchopulmonary Dysplasia Bpd1
- Glp 11